Sarah Wachtman/LinkedIn
Sep 15, 2026, 15:00
Sarah Wachtman: Modeling AAV-Based Gene Therapy for Hemophilia A Using Pediatric Liver Organoids
Sarah Wachtman, Molecular Medicine and Translational Science PhD Graduate Research Student at Wake Forest University Graduate School, shared a post on LinkedIn:
”Excited for the opportunity to share our work using pediatric liver organoids as a model for studying AAV-based gene therapy for hemophilia A at the Charlotte Regional Biomedical Sciences Symposium this afternoon!”
Stay updated with Hemostasis Today.
-
Sep 15, 2026, 15:29Abdul Muqtadir Abbasi: Recognizing Thalassemia Trait Is Essential for Every Physician
-
Sep 15, 2026, 15:17Shehab Mohamed: A New Regional Consensus on HLH Diagnosis and Management
-
Sep 15, 2026, 15:17Sheharyar Raza: Managing Randomness in Artificial Intelligence for Transfusion Medicine
-
Sep 15, 2026, 15:00Ashenafi Tazebew Amare: From Blood Donation to Innovation and Patient Access
-
Sep 15, 2026, 14:56Glanzmann Thrombasthenia Beyond Platelet Transfusion
-
Sep 15, 2026, 14:55Christina Pohlman: The Hidden Complexity of Warfarin Therapy in APS
-
Sep 15, 2026, 14:44Consuela A. Albright: Building a More Connected Sickle Cell Care System
-
Sep 15, 2026, 14:43Andrew Jackson: Cyanosis as a Clue to Central Venous Obstruction
-
Sep 15, 2026, 14:43Andy Darlington: Randomized Evidence for Catheter-Based Treatment of Intermediate-High-Risk PE